top of page
Drug Science

Psychological Support in Psilocybin Therapy - In My Professional Opinion


What is the role of psychological support in psychedelic treatments? In this webinar, Dr Sara Tai will explain why it is essential that psychedelic drugs such as psilocybin are administered in conjunction with psychotherapy.


In such treatments, psychotherapy is primarily delivered at three distinct phases:


  1. Preparation for the psychedelic experience

  2. Guiding the psychedelic experience

  3. Integration of the psychedelic experience.


Dr Sara Tai is a Senior Lecturer in Clinical Psychology at the University of Manchester and Consultant Clinical Psychologist for Greater Manchester Mental Health NHS Foundation Trust. She led the development of the psychological approach and therapeutic model for the Compass Pathways trial of Psilocybin for depression; the largest trial of psychedelics for severe depression.


This webinar was part of Women in Psychedelic Science, a virtual event which showcased the inspiring work of women in psychedelic research.

Drug Science is the leading independent scientific body on drugs in the UK. We rely on donations to provide clear, evidence-based information without political or commercial interference. Drug Science webinars are free, and always will be, so if you’d like to support us then please consider joining the Drug Science Community.

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

bottom of page